MHRA/NIBSC (National Institute for Biological Standards and Control) merger
On 1 April 2013 the National Institute for Biological Standards and Control (NIBSC), currently part of the Health Protection Agency (HPA), will officially become a new ‘centre’ of the Medicines and...
View ArticleApplications sought for a new chair of the Commission on Human Medicines
The Secretary of State for Health is seeking to appoint a chair of the Commission on Human Medicines (CHM)
View ArticleBetter guidance and support for NHS surgeons on vaginal tape and mesh implants
Better guidance and support for NHS surgeons on vaginal tape and mesh implants
View ArticleMHRA Christmas and New Year opening times
This story sets out the MHRA's opening hours over the festive period 2012/13.
View ArticleMHRA supports campaign to warn people about the risks of buying medicines online
The MHRA is involved in campaigns to highlight the risks of buying medicines online. A video has been created to highlight the potential consequences of buying Prescription Only Medicine from illicit...
View ArticleMHRA responds to research paper published in the Lancet
The MHRA has responded to the research paper ‘Failure rates of stemmed metal-on-metal hip replacements’ as published in the Lancet (12 March 2012).
View ArticleSports and body building supplements
Products related to sports and body building frequently come to the MHRA’s attention and are often found to be unacceptable for sale in the UK even though they may be legitimate products in other...
View ArticleReduction in deaths involving co-proxamol after withdrawal from UK market
A study published in the journal ‘Public Library of Science (PLoS) Medicine’ has found that during the six years following the withdrawal of the analgesic co-proxamol in the UK in 2005, there was a...
View ArticleNon executive directors sought for the Medicines and Healthcare products...
The Secretary of State for Health is seeking to appoint up to four non executive directors (NEDs) to the MHRA.
View ArticleMHRA's Enforcement Team featured in episode of BBC's Fake Britain
Coverage of the MHRA's counterfeit drug raids on BBC1's Fake Britain is now available to view on BBC iPlayer
View ArticleInformation about Macrolane injectable dermal filler
The MHRA is aware that the manufacturer Q-Med has decided to discontinue the dermal filler Macrolane for breast augmentation only.
View ArticlePrecautionary recall of Viaspan
A precautionary recall of all batches of Viaspan, a solution used in organ transplant operations, manufactured since 4 July 2011 has been proposed by the manufacturer Bristol-Myers Squibb (BMS).
View Article'Youth friendly' message on medicines for children
Medicines for treating ADHD will now include information written with youngsters and teens in mind, thanks to work by researchers at the University of Leeds and the MHRA.
View ArticleFinal report into PIP breast implants published by expert group led by NHS...
The expert group, led by NHS Medical Director Sir Bruce Keogh, has published its final report into the safety of PIP breast implants.
View ArticleMHRA statement on investigation into Roche
MHRA have issued a statement in response the European Medicines Agency’s update on Roche’s medicine-safety reporting system.
View ArticleMHRA statement on new flu vaccination programme for children
The MHRA has issued a statement in response the Department of Health’s announcement that a new vaccination programme may be implemented in 2014 for children aged between two and 17.
View ArticleMHRA publishes supporting information into 2010 testing of PIP breast implants
The MHRA and the Department of Health have today published supporting information used in the 2010 testing of PIP breast implants. This is additional to the testing results that were announced in...
View ArticlePharmacists encouraged to report adverse drug reactions through Yellow Card...
The MHRA, NHS Employers and the Pharmaceutical Services Negotiating Committee are encouraging community pharmacists to report any adverse drug reactions through the MHRA’s Yellow Card Scheme.
View ArticleDrug safety: reporting systems for the general public
Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA, reports in the British Medical Journal (BMJ) on the latest guidance on monitoring the safety of drugs from the World...
View Article